CD8A and neoplasm: Then, we injected into the first established subcutaneous tumor with pmel-1 CD8+ T cells (CTLs, Thy1.1+), which target the gp100 epitope presented by the tumor cells (Supplementary Fig. S2A), isolated from pmel-1 mice and expanded in culture.